aluminum sulfate has been researched along with Genital Herpes in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awasthi, S; Friedman, HM; Hook, LM; Shaw, CE | 1 |
| Awasthi, S; Bett, AJ; Brooks, B; Cairns, TM; Cohen, GH; Ditto, NT; Espeseth, AS; Friedman, HM; Gindy, ME; Hook, LM; Smith, JS; Swaminathan, G | 1 |
| Bernstein, DI; Bravo, FJ; Cardin, R; Earwood, J; Fairman, J; Farley, N; McNeal, M | 1 |
| Kraynyak, KA; Levinson, MS; Morello, CS; Spector, DH | 1 |
| Bright, H; Chappell, D; Christy, C; Cockle, P; Evans, DM; Eyles, J; Gore, K; Hammond, D; Khodai, T; Lang, S; Loudon, PT; McCluskie, MJ; Townend, T; West, K; Wright, P | 1 |
| Chen, Z; Kraynyak, KA; Lee, KF; Levinson, MS; Morello, CS; Spector, DH | 1 |
| Almond, J; Anderson, SF; Baloglu, S; Catalan, J; Delagrave, S; DiNapoli, JM; Hamberger, JF; Hernandez, H; Kleanthous, H; Londoño-Hayes, P; Mundle, ST; Parrington, M; Zhou, C | 1 |
| Bernstein, D | 1 |
| Bell, SJ; He, Q; Johnson, SL; Mitchell, AR; Morcol, T; Wagner-Bartak, C | 1 |
1 review(s) available for aluminum sulfate and Genital Herpes
| Article | Year |
|---|---|
Glycoprotein D adjuvant herpes simplex virus vaccine.
Topics: Adjuvants, Immunologic; Adolescent; Alum Compounds; Animals; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Herpes Genitalis; Herpes Simplex Virus Vaccines; Humans; Lipid A; Male; Vaccination; Viral Envelope Proteins | 2005 |
8 other study(ies) available for aluminum sulfate and Genital Herpes
| Article | Year |
|---|---|
A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Antigens, Viral; Disease Models, Animal; Female; Glycoproteins; Guinea Pigs; Herpes Genitalis; Herpesvirus Vaccines; Immunotherapy; Oligodeoxyribonucleotides; Secondary Prevention; Treatment Outcome; Vaccines, Subunit | 2017 |
Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Antibody Formation; Biosensing Techniques; Epitopes; Female; Herpes Genitalis; Herpesvirus Vaccines; Immune Evasion; Immunogenicity, Vaccine; Mice, Inbred C57BL; Oligodeoxyribonucleotides; Viral Envelope Proteins; Virus Internalization | 2019 |
The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Viral; Female; Guinea Pigs; Herpes Genitalis; Herpes Simplex Virus Vaccines; Herpesvirus 2, Human; Liposomes; Viral Envelope Proteins; Virus Shedding | 2010 |
Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 disease.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; DNA, Viral; Female; Ganglia, Spinal; Guinea Pigs; Herpes Genitalis; Herpesvirus 2, Human; Herpesvirus Vaccines; Immunization, Secondary; Lipid A; Secondary Prevention; Vaccination; Vaccines, DNA; Vaccines, Inactivated | 2011 |
Single and combination herpes simplex virus type 2 glycoprotein vaccines adjuvanted with CpG oligodeoxynucleotides or monophosphoryl lipid A exhibit differential immunity that is not correlated to protection in animal models.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Disease Models, Animal; Guinea Pigs; Herpes Genitalis; Herpesvirus 2, Human; Herpesvirus Vaccines; Interferon-gamma; Lipid A; Mice; Oligodeoxyribonucleotides; Severity of Illness Index; T-Lymphocytes; Viral Envelope Proteins | 2011 |
Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antigens, Viral; Disease Models, Animal; Female; Ganglia, Spinal; Herpes Genitalis; Herpesvirus 2, Human; Herpesvirus Vaccines; Lipid A; Mice; Mice, Inbred BALB C; Survival Analysis; Vaccination; Vaccines, DNA; Vagina; Virus Shedding | 2012 |
Immunogenicity and efficacy of intramuscular replication-defective and subunit vaccines against herpes simplex virus type 2 in the mouse genital model.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Neutralizing; Antibodies, Viral; Disease Models, Animal; Female; Ganglia, Spinal; Herpes Genitalis; Herpes Simplex Virus Vaccines; Herpesvirus 2, Human; Humans; Injections, Intramuscular; Mice; Mice, Inbred BALB C; Oligodeoxyribonucleotides; Vaccines, Attenuated; Vaccines, Subunit; Vagina; Viral Envelope Proteins | 2012 |
Calcium phosphate nanoparticle adjuvant.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Calcium Phosphates; Epstein-Barr Virus Infections; Female; Guinea Pigs; Herpes Genitalis; Herpesvirus 2, Human; Herpesvirus 4, Human; Humans; Immunoglobulin E; Immunoglobulin G; Inflammation; Male; Mice; Mice, Inbred BALB C; Neutralization Tests; Viral Vaccines | 2000 |